France· FR:67410227
FINGOLIMOD BGR 0,5 mg, gélule
A medicinal product containing chlorhydrate de fingolimod, registered in France by BIOGARAN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE FINGOLIMOD
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930212226plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 gélule(s)EUR 579.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de fingolimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARELEPTANPharmaselect International Beteiligungs GmbH, Vídeň
- SpainFINGOLIMOD ACCORD 0,5 mg CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- PolandAreleptanPharmaselect International Beteiligungs GmbH
- NetherlandsChantico 0,5 mg harde capsulesG.L. Pharma GmbH
- United StatesfingolimodRising Pharma Holdings, Inc.
- FinlandAreleptanPharmaselect International Beteiligungs GmbH
- SwedenAreleptan 0,5 mg Kapsel, hårdPharmaselect International Beteiligungs GmbH
- United KingdomFingolimod 500microgram capsulesSandoz Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areleptan, Chantico
- Belgium · Fingolimod Ab, Fingolimod Eg
- Bulgaria · Chantico, Inzolfi
- Cyprus · Fingolimod Adelco, Fingolimod Remedica
- Czechia · Areleptan, Bonaxon
- Germany · Fingod, Fingolimod 123 Acurae Pharma
- Denmark · Areleptan, Bonaxon
- Estonia · Chantico, Efigalo
- Spain · Fingolimod, Fingolimod Aurovitas
- Finland · Fingolimod, Fingolimod Avansor
- United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
- Greece · Fingolimod Adelco, Fingolimod Medochemie
- Croatia · Areleptan, Arlesias
- Hungary · Bonaxon, Chantico
- Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
- Iceland · Fingolimod, Fingolimod Accord
- Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
- Liechtenstein · Fingolimod Accord, Fingolimod Mylan
- Lithuania · Chantico, Efigalo
- Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
- Latvia · Bonaxon, Chantico
- Malta · Fingolimod Denk, Fingolimod Remedica
- Netherlands · Chantico, Fenoxa
- Norway · Areleptan, Fingolimod Accord
- Poland · Bonaxon, Chantico
- Portugal · Bluesar, Fingolimod Bluefish
- Romania · Fingolimod Dr. Reddys, Fingolimod Msn
- Sweden · Areleptan, Fingolimod Amarox
- Slovenia · Areleptan, Arlesias
- Slovakia · Areleptan, Bonaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1ccffa0-8eea-4ab8-95c7-6b31a8beaebc GET /v1/drugs/f1ccffa0-8eea-4ab8-95c7-6b31a8beaebc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67410227",
"date_amm": "2020-07-23",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE FINGOLIMOD",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.